The company, whose repertoire includes arthroscopy equipment, said sales for the third quarter that ended Sept. 30, 2009 were $175.5 million, compared with $179.4 million in the same quarter of 2008.
However, third quarter results “were substantially better than we had anticipated,” said Joseph Corasanti, president and CEO, and represented an $11 million increase over the second quarter.
Read the release on Conmed’s third quarter report.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
